You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thymic epithelial tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Cancer Trial (single arm for all patients)

Not yet recruiting
  • Cancer
  • single arm for all patients
  • (no location specified)
Sep 26, 2022

Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)

Not yet recruiting
  • Thymic Epithelial Tumor
  • rhGM-CSF，Peginterferon alfa-b2，radiation
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020

Thymic Carcinoma, Thymoma Trial in Milan (Ramucirumab)

Recruiting
  • Thymic Carcinoma
  • Thymoma
  • Ramucirumab
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 12, 2020

Thymic Epithelial Tumors Trial (Pembrolizumab)

Completed
  • Thymic Epithelial Tumors
  • (no location specified)
Jul 7, 2020

Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Thymic Epithelial Tumor Trial (HITOC)

Recruiting
  • Thymic Epithelial Tumor
  • HITOC
  • Shanghai, China
    Shanghai Zhongshan Hospital
Sep 15, 2022

Thymoma and Thymic Carcinoma Trial in Shanghai (concurrent chemoradiation)

Completed
  • Thymoma and Thymic Carcinoma
  • concurrent chemoradiation
  • Shanghai, Shanghai, China
    Kailiang Wu
Feb 5, 2020

Thymic Tumors Trial in Shanghai, Chengdu (KC1036)

Not yet recruiting
  • Thymic Tumors
  • Shanghai, Shanghai, China
  • +1 more
Jan 5, 2023

Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)

Active, not recruiting
  • Thymoma and Thymic Carcinoma
  • Thymosin a1
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 27, 2021

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))

Recruiting
  • Epithelial Tumors, Malignant
  • MT-302 (A)
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Aug 1, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Early Screening of Epithelial Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Fragmentomics
  • (no location specified)
Jun 26, 2023

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Thymic Epithelial Tumor Trial (Toripalimab, Chemotherapy)

Not yet recruiting
  • Thymic Epithelial Tumor
  • (no location specified)
Jan 25, 2021

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Rapid Autopsy and Procurement of Cancer Tissue

Recruiting
  • Thymus Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Thymic Epithelial Tumor Trial in Seoul (pembrolizumab, Radiation)

    Recruiting
    • Thymic Epithelial Tumor
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Mar 18, 2021

    Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

    Active, not recruiting
    • Thymic Carcinoma
    • +3 more
    • VEGFR/PDGFR Dual Kinase Inhibitor X-82
    • Nivolumab
    • Palo Alto, California
    • +6 more
    Sep 21, 2022

    Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • San Fermo Della Battaglia, Como, Italy
    • +1 more
    Nov 2, 2023

    Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)

    Active, not recruiting
    • Locally Advanced or Metastatic Epithelial Tumor
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 14, 2022

    Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • CRX100 suspension for infusion
    • Scottsdale, Arizona
    • +2 more
    Jul 26, 2022